SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-277680
Filing Date
2015-08-05
Accepted
2015-08-05 07:17:26
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d940533d10q.htm 10-Q 661742
2 EX-31.1 d940533dex311.htm EX-31.1 8609
3 EX-31.2 d940533dex312.htm EX-31.2 8583
4 EX-32.1 d940533dex321.htm EX-32.1 3903
5 EX-32.2 d940533dex322.htm EX-32.2 3863
  Complete submission text file 0001193125-15-277680.txt   3284267

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20150630.xml EX-101.INS 493818
7 XBRL TAXONOMY EXTENSION SCHEMA cnce-20150630.xsd EX-101.SCH 38618
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnce-20150630_cal.xml EX-101.CAL 60768
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnce-20150630_def.xml EX-101.DEF 127457
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20150630_lab.xml EX-101.LAB 327439
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20150630_pre.xml EX-101.PRE 246278
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 151027452
SIC: 2834 Pharmaceutical Preparations